• Profile
Close

Pro-neurotensin/neuromedin N and risk of incident metabolic syndrome and diabetes mellitus in the REGARDS cohort

Journal of Clinical Endocrinology and Metabolism May 28, 2021

Nicoli CD, Carson AP, Plante TB, et al. - Among 3,772 participants from the REasons for Geographic And Racial Differences in Stroke study, this investigation was carried out to determine whether and how neurotensin’s stable precursor, pro-neurotensin/neuromedin N (pro-NT/NMN) was associated with incident metabolic syndrome (MetS) and diabetes mellitus (DM). Median [IQR] plasma pro-NT/NMN was 160 [118-218] pmol/L. MetS was experienced by 564 (of 2,770 without baseline MetS) participants and DM by 407 (of 3,030 without baseline DM). Findings demonstrated the link of pro-NT/NMN with MetS as well as with two components, dysglycemia and low HDL, possibly explained by insulin resistance.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay